Welcome to LookChem.com Sign In|Join Free
  • or
2-Butanone, 3-chloro-4-[3-(trifluoromethyl)phenyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

199804-00-7

Post Buying Request

199804-00-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

199804-00-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 199804-00-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,9,8,0 and 4 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 199804-00:
(8*1)+(7*9)+(6*9)+(5*8)+(4*0)+(3*4)+(2*0)+(1*0)=177
177 % 10 = 7
So 199804-00-7 is a valid CAS Registry Number.

199804-00-7Relevant academic research and scientific papers

SUBSTITUTE 1, 6-NAPHTHYRIDINES FOR USE AS SCD INHIBITORS

-

Page/Page column 38, (2009/06/27)

The present invention relates to substituted tetrahydronaphthyridine (THN) compounds of the formula (I) and salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for inhibiting SCD activity.

N-THIAZOLYL-1, 2, 3, 4-TETRAHYDRO-6-ISOQUINOLINECARBOXAMIDE DERIVATIVES AS INHIBITORS OF STEAROYL COENZYME A DESATURASE

-

Page/Page column 37-38, (2010/01/07)

The present invention relates to substituted thiazole compounds of the formula (I) wherein Z represents (A), (B), (C) and (D) where * represents the point of attachment and salts thereof, to pharmaceutical compositions containing them and their use in med

Use of thiazole derivatives and analogues in disorders caused by free fatty acids

-

, (2009/06/27)

There is provided a use of a compound of formula I, wherein X, T, Y, W, A1, A2, R1, R5 and R6 have meanings given in the description, for the manufacture of a medicament for the treatment of a disorde

NEW COMBINATION FOR USE IN THE TREATMENT OF CANCER

-

Page/Page column 76; 77, (2008/12/06)

There is provided combination products comprising (a) a compound of formula (I): wherein X, Y, T, W, A1, A2 R1, R5 and R6 have meanings given in the description, and (b) tamoxifen or an aromatase inhi

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 199804-00-7